Advancing Breast Cancer Care with Alpelisib
Discover the targeted therapy revolutionizing treatment for advanced breast cancer.
Get a Quote & SampleProduct Core Value
Alpelisib
Alpelisib is a crucial targeted therapy drug, categorized as a PI3K inhibitor, designed to combat advanced or metastatic, hormone receptor-positive breast cancer. It plays a vital role by specifically targeting and blocking the PI3K pathway within cancer cells, a pathway often overactive due to PIK3CA gene mutations, which can lead to resistance to hormonal therapies.
- Explore the efficacy of Alpelisib for breast cancer patients, focusing on managing hormone receptor-positive subtypes.
- Understand how this PI3K inhibitor works in conjunction with fulvestrant to inhibit cancer cell growth pathways.
- Learn about the crucial role of the PIK3CA gene mutation in determining treatment suitability for advanced breast cancer.
- Discover the importance of comprehensive side effect management strategies for targeted therapy for metastatic breast cancer.
Key Advantages
Targeted Action
Alpelisib offers a precise approach to treating breast cancer by inhibiting the PI3K pathway, a critical factor in the progression of hormone receptor-positive, HER2-negative metastatic disease.
Improved Patient Outcomes
When combined with fulvestrant, Alpelisib demonstrates significant potential in keeping cancer from growing, offering a valuable advancement in metastatic breast cancer treatment options.
Oral Administration
As an oral pill, Alpelisib provides a more convenient treatment regimen for patients, allowing for home-based administration alongside the necessary hormonal therapy.
Key Applications
Advanced Breast Cancer Therapy
Specifically indicated for patients with advanced or metastatic, hormone receptor-positive breast cancer that has progressed during or after hormonal therapy, especially those with a PIK3CA gene mutation.
Oncology Research & Development
Serves as a key active pharmaceutical ingredient (API) in ongoing oncology research, aiding the development of new treatment protocols and understanding of cancer resistance mechanisms.
Pharmaceutical Manufacturing
Produced as a high-quality pharmaceutical chemical, meeting stringent standards for use in the synthesis of life-saving medications within the pharmaceutical industry.
Personalized Medicine
Facilitates personalized medicine approaches by targeting specific genetic mutations like PIK3CA, tailoring treatment to individual patient profiles for maximum efficacy.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).